
Granite Bio makes $100m debut, and other bio financings
Swiss startup Granite Bio has carved out $100 million in a pair of financings for its pipeline of potentially first-in-class antibodies for autoimmune diseases. The Basel-based company has one antibody already in clinical trials and another due to start …